Authors

• Christopher Parrish (ORCID: https://orcid.org/0000-0001-9627-736X)
• Kevin Boyd (ORCID: https://orcid.org/0000-0002-5362-6934)
• Sharon Gillson
• John A. Snowden (ORCID: https://orcid.org/0000-0001-6819-3476)
• A. John Ashcroft
• Mamta Garg (ORCID: https://orcid.org/0000-0002-3560-0132)
• Gordon C Cook (ORCID: https://orcid.org/0000-0003-1717-0412)
• David Allan Cairns (ORCID: https://orcid.org/0000-0002-2338-0179)
• Mark T. Drayson (ORCID: https://orcid.org/0000-0002-1528-7564)
• Mark Cook (ORCID: https://orcid.org/0000-0001-8647-9208)
• Roger G. Owen
• Kwee Yong (ORCID: https://orcid.org/0000-0002-6487-276X)
• Jeanine Richards
• Anna Hockaday
• Ruth de Tute (ORCID: https://orcid.org/0000-0001-8001-8873)
• Hamdi Sati
• Catherine Olivier
• Lesley Roberts
• Jamie Cavenagh
• Ethan R Senior

Institutions

• University of Leeds (GB)
• University College London Hospitals NHS Foundation Trust (GB)
• Barts Health NHS Trust (GB)
• Leeds Teaching Hospitals NHS Trust (GB)
• Leicester Royal Infirmary (GB)
• Singleton Hospital (GB)
• Royal Marsden Hospital (GB)
• Cancer Research UK Clinical Trials Unit (GB)
• Mid Yorkshire Hospitals NHS Trust (GB)
• University College London (GB)
• Bristol-Myers Squibb (Switzerland) (CH)
• University of Birmingham (GB)

Publication Details

Journal

The Lancet Haematology

Published

2024-09-06

DOI

https://doi.org/10.1016/s2352-3026(24)00249-7

Citations

8

Primary Topic

Multiple Myeloma Research and Treatments

Type

article

Field-Weighted Citation Impact

3.64

Funders

• Cancer Research UK
• Medical Research Council